Centers for Autism and Developmental Disabilities Research and Epidemiology (CADDRE): Study to Explore Early Development (SEED) 3
Closed Posted
- Opportunity number
- RFA-DD-16-001
- Agency
-
Centers for Disease Control and Prevention
Department of Health and Human Services
- Applications due
- Award size
- Not on record
Opportunity facts
- Assistance listings
- Funding instrument
- Cooperative Agreement
- Category
-
- Health
- Eligible applicants
-
- Tribal Governments (Federally Recognized)
- County Governments
- Small Businesses
- Independent School Districts
- Higher Education Inst. (Public)
- 501(c)(3) Nonprofits
- Special District Governments
- Unrestricted
- Other
- City/Township Governments
- Public or Indian Housing Auth.
- Non-501(c)(3) Nonprofits
- Higher Education Inst. (Private)
- For Profit Organizations
- State Governments
- Tribal Organizations (Not Federally Recognized)
Opportunity details come from Grants.gov. Updated .
Synopsis
2 versions
Update #2 · Latest ·
This Funding Opportunity Announcement (FOA) is for applicants to support:Component A) continuation of the epidemiological research capability of the Centers for Autism and Developmental Disabilities Epidemiology (CADDRE) Network with implementation of the Study to Explore Early Development (SEED) Phase 3.SEED is a case-control study of genetic and environmental risk and protective factors for autism with multiple-source ascertainment of case and comparison groups; SEED Phase 3 is a continuation of SEED 1 and SEED 2 with the same basic study design but with some enhancements in study recruitment and some reductions in data collection.Component B) implementation of the SEED Central Laboratory and Biosample Repository (CLBR) to support the maintenance and storage of the SEED Phase 1 and Phase 2 biosample repository and support the collection and storage of the SEED Phase 3 biosamples. Applicants who apply for Component A may also apply for Component B. Component C) development and implementation of a study protocol and feasibility assessment for a follow-up study of SEED 1 participants.Component C is a project to develop and implement a short protocol and feasibility assessment for conducting a follow-up of the children who enrolled in SEED 1 and completed the SEED 1 study data collection protocol.
Update #1 ·
This Funding Opportunity Announcement (FOA) is for applicants to support: Component A) continuation of the epidemiological research capability of the Centers for Autism and Developmental Disabilities Epidemiology (CADDRE) Network with implementation of the Study to Explore Early Development (SEED) Phase 3. SEED is a case-control study of genetic and environmental risk and protective factors for autism with multiple-source ascertainment of case and comparison groups; SEED Phase 3 is a continuation of SEED 1 and SEED 2 with the same basic study design but with some enhancements in study recruitment and some reductions in data collection. Component B) implementation of the SEED Central Laboratory and Biosample Repository (CLBR) to support the maintenance and storage of the SEED Phase 1 and Phase 2 biosample repository and support the collection and storage of the SEED Phase 3 biosamples. Applicants who apply for Component A may also apply for Component B. Component C) development and implementation of a study protocol and feasibility assessment for a follow-up study of SEED 1 participants. Component C is a project to develop and implement a short protocol and feasibility assessment for conducting a follow-up of the children who enrolled in SEED 1 and completed the SEED 1 study data collection protocol.
Eligibility
Applicants must provide the following in Appendix A of the application:2014 vital statistics data on number of births for all state territories, counties, etc included in the site study catchment area and a map of the study catchment area.Data that describes the racial/ethnic/socioeconomic characteristics of the proposed study catchment area and study population (e.g., from official reports, documents, websites).Evidence of negotiation with state vital records holder concerning applicant’s terms of access to birth certificate data (e.g., letter on official letterhead, MOU, or other official documentation)Evidence of negotiation (e.g., letter on official letterhead, MOU, or other official documentation) of established partnerships with ASD/DD ascertainment source(s) (might be clinics, healthcare providers, school systems, state disability centers, etc.).Provide documentation in Appendix A with appropriate labels indicating to which criterion above (1 through 4) the documentation pertains. If your application is incomplete or non-responsive to the special eligibility requirements listed in this section, it will not enter into the review process.
Files
| File | Type | Posted |
|---|---|---|
| RFA-DD-16-001 amendment 2 Q&As.pdf |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar grant opportunities
- Ask GovTribe AI about this opportunity